London, UK (PRWEB) September 17, 2014
The in vitro diagnostics (IVD) marketplace is a subset of the total medical technology market, focusing on molecular diagnostics for conditions such as infectious diseases, sexually-transmitted diseases, cancer, chronic diseases, and genetic testing. The IVD market value is projected to be worth around USD 70 billion by the end of 2017. The major drivers of the market’s growth include the shift to point-of-care testing; need for speed, which is evidenced by the explosion for raid and minimally-invasive diagnostic tools; demand from emerging markets; and ageing population in a lot of countries. Roche Diagnostics, Siemens Healthcare, Abbot Laboratories, Agilent Technologies, diaDexus, among others, are the prominent players in the market.
In-demand research report “2014 World In Vitro Diagnostics Industry: Market Shares and Country Forecasts for 400 Assays, 20 Market Segments and 14 Test Locations--Emerging Opportunities and Business Expansion Strategies for Suppliers” worked out by Venture Planning Group (VPG) is now available at MarketPublishers.com.
Title: 2014 World In Vitro Diagnostics Industry: Market Shares and Country Forecasts for 400 Assays, 20 Market Segments and 14 Test Locations--Emerging Opportunities and Business Expansion Strategies for Suppliers
Published: August, 2014
Price: US$ 175,000.00
The report draws up an elaborate picture of the in vitro diagnostics market, covering facilities performing respective tests in various countries, along with test volume forecasts and sales projections by country. Market segmentation analysis is included, focusing on such segments as chemistry and immunoassay, hematology and flow cytometry, microbiology and serology, blood banking, coagulation, histology and cytology, and urinalysis. The report provides a by-country analysis of the market structure, dynamics, trends, growth, size, and key suppliers; sales and test volume forecasts for more than 400 diagnostic procedures. It gives an up-close look at existing and emerging tests, reviews the latest instrumentation technologies, besides providing a feature comparison of high-, medium-, and low-volume/POC analysers. A detailed technology review is included, comprising an assessment of diagnostic technologies (current and emerging) and their potential market applications; as well as a review of companies developing/marketing novel products and technologies by test. Strategic recommendations are offered as well. Additionally, the study presents a granular assessment of major diagnostic product producers and emerging market entrants, covering their product portfolios, sales, marketing strategies, collaborative arrangements and innovative products in research and development.
- Comprehensive analysis of the worldwide in vitro diagnostics market.
- Detailed by-country market analyses, with a focus on France, Germany, Italy, Japan, Spain, the UK, and the USA.
- Comprehensive market segmentation analysis.
- Review of emerging tests and instrumentation.
- Examination of the key product development opportunities.
- Overview of alternative market penetration strategies.
- Investigation of potential market entry risks and barriers.
- Assessment of the competitive landscape along with extensive company profiles.
- Forecast of the global in vitro diagnostics market.
More in-demand market research reports by the publisher can be found at VPG page.